Invent The Future - UC Davis Health System

More documents

Recommendations

Info

Post Procedure Care • Monitor patients in ICU or CCU for 24 hours • Monitor closely for potential post-op complications Bleeding Late AV block (ECG monitoring) CHF Renal dysfunction CVA
CCU/CTICU • Systolic blood pressure control Manage between 110 and 130 mmHg for the first 24 hours • Antiplatelet therapy 81-325 mg aspirin PO QD Optional: Clopidogrel 75 mg PO QD for six months (or 250 mg ticlodipine PO BID for patients who are allergic to aspirin or clopidogrel)
Page 1 and 2: TAVR: It’s a Career, Not Just a P
Page 3 and 4: Before You Start • Do you have a
Page 5 and 6: - Etiology Calcific degenerative A
Page 7 and 8: TAVI Trans femoral High Risk TF 1:1
Page 9 and 10: 30% Absolute Reduction in Cardiovas
Page 11 and 12: Valve Size Selection • The SAPIEN
Page 13 and 14: 23 mm or 26 mm Valve? • The prima
Page 15: Prepare the Patient • RIJ large s
Page 20 and 21: 9000TFX Edwards SAPIEN Transcathete
Page 22 and 23: Edwards SAPIEN Valve Model 9000TFX
Page 24 and 25: RetroFlex 3 Delivery System Tapered
Page 27 and 28: Rapid Ventricular Pacing: Test Run
Page 29 and 30: Crossing Native Valve • Flex cath
Page 32: Edwards SAPIEN Valve Valve Foreshor
Page 35: •Reinsert introducer into sheath
Page 39 and 40: Registry • Mandatory reporting of
Page 41 and 42: Boston Scientific - Lotus TM Valve
Page 43: Thanks

Invent The Future - UC Davis Health System

Create successful ePaper yourself

Delete template?

Save as template?